PTPRJ and familial pancreatic carcinoma: Our group also demonstrated that virus-mediated PTPRJ overexpression is effective in preclinical models of both thyroid and pancreatic cancer [11, 12], suggesting that PTPRJ is a proof-of-principle therapeutic gene.